Research
FORUM TRANSCRIPT

ViewRay – MR Linac Market Update & Competitive Analysis

  • Multi Asset
  • Healthcare
  • North America
PREMIUM

Specialist

Former VP at ViewRay Inc

Agenda

  • ViewRay’s (NASDAQ: VRAY) customer profile and installation ease and costs vs those of players such as Elekta (STO: EKTA B) and Philips (AMS: PHIA)
  • Key purchasing criteria – MR Linac vs traditional and alternatives
  • M&A opportunities, competitive analysis and new market entrants
  • Impact of Siemens Healthineers' (ETR: SHL) 2021 acquisition of Varian on ViewRay's radiation oncology market position
  • 2022 expectations, RO-APM (Radiation Oncology Alternative Payment Model) outlook and other regulatory hurdles

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo